GB2148296A - 1,2-dithiolan derivatives, process for their production pharmaceutical compositions containing them and their use - Google Patents

1,2-dithiolan derivatives, process for their production pharmaceutical compositions containing them and their use Download PDF

Info

Publication number
GB2148296A
GB2148296A GB08426657A GB8426657A GB2148296A GB 2148296 A GB2148296 A GB 2148296A GB 08426657 A GB08426657 A GB 08426657A GB 8426657 A GB8426657 A GB 8426657A GB 2148296 A GB2148296 A GB 2148296A
Authority
GB
United Kingdom
Prior art keywords
compound according
compound
dithiolane
substituted
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB08426657A
Other languages
English (en)
Other versions
GB8426657D0 (en
Inventor
Frank Michael Unger
Ekke Liehl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8426657D0 publication Critical patent/GB8426657D0/en
Publication of GB2148296A publication Critical patent/GB2148296A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
GB08426657A 1983-10-24 1984-10-22 1,2-dithiolan derivatives, process for their production pharmaceutical compositions containing them and their use Pending GB2148296A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5746/83A CH656382A5 (de) 1983-10-24 1983-10-24 Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.

Publications (2)

Publication Number Publication Date
GB8426657D0 GB8426657D0 (en) 1984-11-28
GB2148296A true GB2148296A (en) 1985-05-30

Family

ID=4298650

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08426657A Pending GB2148296A (en) 1983-10-24 1984-10-22 1,2-dithiolan derivatives, process for their production pharmaceutical compositions containing them and their use

Country Status (19)

Country Link
JP (1) JPS60115574A (xx)
AU (1) AU3454984A (xx)
BE (1) BE900854A (xx)
CH (1) CH656382A5 (xx)
DE (1) DE3438585A1 (xx)
DK (1) DK505684A (xx)
ES (1) ES8601183A1 (xx)
FI (1) FI844153L (xx)
FR (1) FR2553663A1 (xx)
GB (1) GB2148296A (xx)
GR (1) GR80730B (xx)
HU (1) HUT36823A (xx)
IL (1) IL73278A0 (xx)
IT (1) IT1199212B (xx)
LU (1) LU85607A1 (xx)
NL (1) NL8403083A (xx)
PT (1) PT79389B (xx)
SE (1) SE8405275L (xx)
ZA (1) ZA848303B (xx)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001440A2 (en) * 1996-07-05 1998-01-15 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
EP0869126A1 (en) * 1997-04-02 1998-10-07 Sankyo Company Limited Dithiolan derivatives, their preparation and their therapeutic effect
EA003424B1 (ru) * 1998-12-15 2003-04-24 Ле Лаборатуар Сервье Новые соединения 1,2-дитиолана, способ их получения и содержащие их фармацевтические составы

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334612A (en) * 1988-11-09 1994-08-02 Asta Pharma Aktiengesellschaft Pharmaceutical compositions containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
JPH05337004A (ja) * 1992-06-09 1993-12-21 Gotoujiyuu:Kk ランドセル
JPH077521U (ja) * 1993-07-13 1995-02-03 ナース鞄工株式会社 ランドセル
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
JP2000169371A (ja) * 1998-10-02 2000-06-20 Sankyo Co Ltd ジチオラン誘導体を含有する医薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2933430A (en) * 1959-01-22 1960-04-19 Du Pont Lipoic acid compositions

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001440A2 (en) * 1996-07-05 1998-01-15 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
WO1998001440A3 (en) * 1996-07-05 1998-05-14 Us Health Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
US6046228A (en) * 1996-07-05 2000-04-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
AU737038B2 (en) * 1996-07-05 2001-08-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
EP0869126A1 (en) * 1997-04-02 1998-10-07 Sankyo Company Limited Dithiolan derivatives, their preparation and their therapeutic effect
US6013663A (en) * 1997-04-02 2000-01-11 Sankyo Company, Limited Dithiolan derivatives, their preparation and their therapeutic effect
EP1070710A2 (en) * 1997-04-02 2001-01-24 Sankyo Company Limited Dithiolan derivatives, their preparation and their therapeutic effect
EP1070710A3 (en) * 1997-04-02 2001-03-21 Sankyo Company Limited Dithiolan derivatives, their preparation and their therapeutic effect
US6313164B1 (en) 1997-04-02 2001-11-06 Sankyo Company, Limited Dithiolin derivatives, their preparation and their therapeutic effect
EA003424B1 (ru) * 1998-12-15 2003-04-24 Ле Лаборатуар Сервье Новые соединения 1,2-дитиолана, способ их получения и содержащие их фармацевтические составы

Also Published As

Publication number Publication date
PT79389B (en) 1986-09-08
IT8449056A1 (it) 1986-04-24
GR80730B (en) 1985-02-20
ES537010A0 (es) 1985-11-01
ZA848303B (en) 1986-06-25
GB8426657D0 (en) 1984-11-28
DK505684D0 (da) 1984-10-23
IT8449056A0 (it) 1984-10-24
SE8405275D0 (sv) 1984-10-22
PT79389A (en) 1984-11-01
DK505684A (da) 1985-04-25
SE8405275L (sv) 1985-04-25
IL73278A0 (en) 1985-01-31
LU85607A1 (fr) 1985-06-19
JPS60115574A (ja) 1985-06-22
FI844153A0 (fi) 1984-10-22
HUT36823A (en) 1985-10-28
CH656382A5 (de) 1986-06-30
AU3454984A (en) 1985-05-02
BE900854A (fr) 1985-04-19
NL8403083A (nl) 1985-05-17
FI844153L (fi) 1985-04-25
ES8601183A1 (es) 1985-11-01
FR2553663A1 (fr) 1985-04-26
IT1199212B (it) 1988-12-30
DE3438585A1 (de) 1985-05-02

Similar Documents

Publication Publication Date Title
JP2978850B2 (ja) 2−アミノベンズアゼピン誘導体
EP0074070A1 (de) Harnstoffderivate, Verfahren zu ihrer Herstellung und diese enthaltende Medikamente sowie deren Verwendung
DE60220890T2 (de) Benzo[f]isoindolderivate mit affinität zum ep4-rezeptor
JP3145715B2 (ja) 無水7−([1α,5α,6α]−6−アミノ−3−アザビシクロ[3.1.0]ヘキサ−3−イル)−6−フルオロ−1−(2,4−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリディン−3−カルボン酸メタンスルホン酸塩の新規な結晶形態
US4757069A (en) Pyridazodiazepine derivatives
GB2158440A (en) 4,5,6,7-Tetrahydroimidazo[4,5-c]pyridine derivatives
GB2148296A (en) 1,2-dithiolan derivatives, process for their production pharmaceutical compositions containing them and their use
US4567182A (en) Compounds endowed with immunomodulating activity
EP0002228A2 (en) Hydroxy naphthoquinone derivatives, their preparations for treating and preventing theileriosis in cattle and sheep, processes for their synthesis; naphthoquinone derivatives
JPH0559105B2 (xx)
BRPI0620647A2 (pt) derivados de furopirimidina ciclicamente substituìdos, processo para a preparação e uso dos mesmos e medicamento
JP4277015B2 (ja) ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物
EP0058134B1 (en) Novel bis- and poly-disulfides having immunostimulant activity
US4587250A (en) Thiazaspirane derivatives, process for their preparation, and medicaments
KR20220095094A (ko) 피페론구민계 화합물 및 이를 포함하는 면역조절제
AU660641B2 (en) Novel glucohydrolase inhibitors useful as antidiabetic agents
US3917833A (en) Amino-substituted benzocycloheptenones for inducing sleep
CA1164862A (en) Indol acetic derivates, process for producing the same and pharmaceutical compositions comprising the same
CN117343064B (zh) 一种具有抗病毒作用的嘧啶衍生物的制备与应用
SU1512482A3 (ru) Способ получени производных пиримидоизохинолина или их фармацевтически приемлемых солей
EP0847400B1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
JPWO2018088439A1 (ja) T細胞集団の改変方法
KR950013764B1 (ko) 피로글루타미드 유도체, 그 제조방법, 및 그것을 함유하는 치매증 치료제
US3997594A (en) Hydroxamic acids of alicyclic amino acids
EP0610076B1 (en) Cytotoxic compounds